Current location - Health Preservation Learning Network - Health preserving class - Investigation and analysis report on pharmaceutical market
Investigation and analysis report on pharmaceutical market
Investigation Report on China Pharmaceutical Market in 2005-2006

Report catalogue

The first part is the current situation of the pharmaceutical industry.

Chapter I Operation of Pharmaceutical Industry in China

Section 1 General Operation of Pharmaceutical Industry in China

I. Profits and losses of the pharmaceutical industry in China from 2002 to 2005

Two, 2002-2005 China pharmaceutical industry production and marketing situation.

Three. Benefits of China Pharmaceutical Industry in 2002-2005

Four. China Pharmaceutical Industry Development Index from 2002 to 2005

Section II Economic Comparison of Pharmaceutical Sub-sectors in China

I. Profits and losses of pharmaceutical sub-sectors in China from 2002 to 2005

Two, 2002-2005 China pharmaceutical industry production and marketing situation.

III. From 2002 to 2005, the pharmaceutical industry in China benefited.

IV. China Pharmaceutical Industry Development Index from 2002 to 2005.

Section III Economies of Scale of China Pharmaceutical Industry

I. Profits and losses of pharmaceutical enterprises in China from 2002 to 2005

II. Production and marketing of pharmaceutical enterprises in China from 2002 to 2005.

III. Benefit Status of Pharmaceutical Enterprises in China from 2002 to 2005.

IV. Development Index of Pharmaceutical Enterprises in China from 2002 to 2005.

Section IV Economic Operation of Drug Property Rights in China

I. Economic gains and losses of drug property rights in China from 2002 to 2005

Two, 2002-2005 China pharmaceutical industry economic production and marketing situation.

Third, the economic benefits of pharmaceutical industry in China from 2002 to 2005.

Four, 2002-2005 China pharmaceutical industry economic development index.

Chapter II Characteristics and Investment Environment of Pharmaceutical Investment

Section 1 Research on Investment Characteristics of Pharmaceutical Industry

I. Characteristics of the pharmaceutical industry

Second, the status quo of the pharmaceutical industry

Third, industry concentration analysis

Fourth, the upstream and downstream industrial chain of medicine.

Five, the pharmaceutical industry barriers

Section II Research on Investment and Financing Environment of Pharmaceutical Industry in 2004

I. Industrial policy

Second, the market access conditions

Third, the industry and market management system

Four. Relevant policy environment

Verb (abbreviation of verb) industry reform

The third quarter pharmaceutical industry investment analysis

First, the investment value of each sub-industry

Second, Chinese medicine companies have the most investment value.

Third, the investment value of listed companies.

Four, the five major risks of pharmaceutical investment industry

The third chapter reviews the hot spots of China pharmaceutical industry.

Section 1 GMP certification analysis

I. Impact of GMP certification on the market

Second, attach importance to GMP certification of small and medium-sized pharmaceutical enterprises.

Third, after GMP certification, the overall overcapacity of China's pharmaceutical industry is still intensifying.

Fourth, the marketing trend in the post-GMP certification era

Verb (abbreviation of verb) How will pharmaceutical enterprises consolidate and expand GMP certification results?

Section 2 M&A boom analysis

First, the perspective of pharmaceutical mergers and acquisitions

Second, the motivation, characteristics and trends of pharmaceutical industry restructuring

Third, analysis of the causes and characteristics of M&A wave in China pharmaceutical industry.

Fourthly, the motivation analysis of international pharmaceutical companies' M&A and its enlightenment to China.

V. Pharmaceutical Industry In 2004, M&A reached another climax of restructuring.

6. M&A will become the main theme of the rapid development of the pharmaceutical industry in China.

Seven, the forecast analysis of pharmaceutical industry mergers and acquisitions.

Section III Analysis of Medical Reform

Chapter IV Investment Analysis of Pharmaceutical Industry

The first section overall investment situation

I. Number of new and under construction projects

Second, the distribution of investment projects by industry

Third, the direction of the use of funds

Four. Sources of investment funds

V ownership structure of investors

Completion of intransitive verb investment project

Seven. Analysis of investment benefit and existing problems

Section 2 Analysis of Key Investment Projects

I. Chemical API Enterprise Project

Second, the chemical enterprise project

Third, Chinese medicine enterprise projects

Fourth, medical device enterprise projects

Five, biopharmaceutical enterprise projects

The second part is the global pharmaceutical market analysis.

Chapter V Market Size of the World and Its Major Regions

Section 1 Global Pharmaceutical Market Scale

I. Development of global pharmaceutical market scale from 2002 to 2005

Second, the global pharmaceutical market sales by region in 2002-2005

Three. Ranking and sales of major treatment categories in the world from 2002 to 2005

Four, 2002-2005 global best-selling prescription drug sales and its growth analysis

Five, 200 1 ~ 2002 global top 13 pharmaceutical market sales (by country)

The development trend of new drugs in 2003 and beyond.

Section 2 Analysis of the World OTC Market

First, the overall trend of the transformation from Rx to OTC

Second, the driving force for the transformation from Rx to OTC

Thirdly, the security mechanism of Rx to OTC conversion.

Section III Analysis of the Current Situation of American Pharmaceutical Industry

First, the overall situation of the American pharmaceutical market

Second, the analysis of the current situation of the American pharmaceutical market

Third, modern medicine retail management in the United States

Section 4 Japan

I. General situation of Japanese pharmaceutical market

Second, the production of Chinese herbal medicines in Japan

Third, the internationalization of the Japanese pharmaceutical market.

Section 5 Europe

I. Overview of the European pharmaceutical market

Second, the analysis of the differences between American and European medical management systems

Third, the European pharmaceutical market analysis

Chapter VI Operation Analysis of Global Leading Pharmaceutical Enterprises

Section 1 General Situation Analysis of Leading Pharmaceutical Enterprises in the World

I. Analysis of overall operation from 2003 to 2005

Second, R&D investment analysis

Section II Pfizer's Operation in 2003-2005

I. Total sales in 2003-2005

Two. Sales of main products in 2003-2005

Third, new product development and listing analysis

Fourth, the problems and countermeasures of enterprises

Section III Operation of Roche Pharmaceuticals in 2003-2005

Section IV Operation of Pepsi Squibb from 2003 to 2005

Section V Operation of Novartis Pharmaceuticals in Switzerland from 2003 to 2005

Section VI Operation of Merck Pharmaceuticals in 2003-2005

Section 7 Operation of GlaxoSmithKline in 2003-2005

Section VIII Operation of Nanxing Pharmaceutical in India from 2003 to 2005

Section 9 Operation of Major Biopharmaceutical Companies in the World from 2003 to 2005

Chapter VII Global Pharmaceutical R&D Analysis

Section 1 Global Drug R&D Analysis

First, the analysis of the current situation of medical development research in the world

Second, the main problems encountered in the research of world medical development

Section 2 Global Analysis of Expired and Expired Patented Drugs

Patented drugs whose patents have expired or will expire.

Second, 1998-2007 global best-selling drugs with expired patents

Third, research and development of global antiviral drugs.

Part III Chemical Pharmaceutical Industry

Chapter VIII Chemical Raw Material Medicine Industry

Section 1 General Operation of Chemical Raw Materials

I. Profits and losses of chemical raw material medicine industry from 2002 to 2005

II. Production and marketing of chemical raw materials medicine industry in 2002-2005

Three. Industrial benefit of chemical raw materials in 2002-2005

Four. Development Index of Chemical API Industry in 2002-2005

Section 2 Economies of Scale of Chemical Raw Materials

I. Profits and losses of large, medium and small enterprises of chemical raw materials from 2002 to 2005

Two, 2002-2005, chemical raw materials production and sales enterprises.

Three. Benefits of large, medium and small enterprises of chemical raw materials in 2002-2005

Four. Development index of large, medium and small enterprises of chemical raw materials in 2002-2005

Section 3 Property Right Economy of Chemical Raw Materials

I. Economic gains and losses of property rights of chemical raw materials in 2002-2005

II. Economic production and marketing of chemical raw materials from 2002 to 2005.

III. Economic benefits of chemical raw materials from 2002 to 2005.

IV. Economic development indicators of chemical raw materials in 2002-2005.

The fourth quarter chemical raw material output analysis

I. Output growth in 2002-2005

II. Monthly Changes of Chemical Raw Materials and Drugs in 2004-2005

Three. Production of chemical raw materials in major areas

Section 5 Operation of Chemical Raw Materials in Major Areas

I. General situation

Two. Operation of Chemical Raw Material Medicine Industry in Hebei Province

Three. Operation of Chemical Raw Material Medicine Industry in Zhejiang Province

Four. Operation of Chemical Raw Material Medicine Industry in Shandong Province

Verb (abbreviation of verb) Operation of chemical raw material medicine industry in Heilongjiang Province

Intransitive Verb Operation of Chemical Raw Material Medicine Industry in Jiangsu Province

Seven. Operation of Tianjin Chemical Raw Material Medicine Industry

Section 6 Operation of Leading Enterprises of Chemical Raw Materials

I. Analysis on the Operation of the Top Ten Enterprises of Chemical Raw Materials in 2003-2005

2. Analysis of Top Chemical Raw Materials 100 Enterprises in 2003-2005

Section 7 Foreign Trade of Chemical Raw Materials in China

I. General situation

Two. Imports from 2002 to 2005

Three. Export situation from 2002 to 2005

Fourth, the export of chemical raw materials

Verb (abbreviation of verb) foreign trade policy of chemical raw materials

Chapter IX Operation of Chemical Preparations Industry

Section 1 General Operation of Chemicals

I. Profits and losses of chemical preparation industry from 2002 to 2005

II. Production and Marketing Situation of Chemical Industry in 2002-2005

Three. Benefit of Chemical Industry in 2002-2005

Four. Development Index of Chemical Industry in 2002-2005

Section 2 Economies of Scale of Chemical Preparations

I. Profits and losses of large, medium and small enterprises of chemical preparations in 2002-2005

2. Production and marketing of chemicals in large, medium and small enterprises from 2002 to 2005.

Three. Benefit of chemical preparation enterprises in 2002-2005

IV. Development Index of Chemical Reagent SMEs in 2002-2005

Section 3 Property Right Economy of Chemical Preparations

I. Economic gains and losses of chemical agent property rights in 2002-2005

Two, 2002-2005, the economic production and marketing of chemical preparations.

III. Economic Benefits of Chemical Property Rights from 2002 to 2005

IV. Economic Development Index of Chemical Industry in 2002-2005

The fourth quarter chemical production situation

I. Output growth in 2002-2005

II. Monthly Changes of Chemical Raw Materials and Drugs in 2004-2005

III. Main fields of chemical production

Section 5 Operation of Chemical Agents in Main Fields

I. General situation

Two. Operation of Chemical Preparations Industry in Jiangsu Province

Three. Operation situation of chemical preparation industry in Guangdong

Four. Operation of chemical preparation industry in Shanghai

Verb (abbreviation of verb) Operation of Chemical Industry in Zhejiang Province

VI. Operation of Shaanxi Chemical Industry

Seven. Operation of chemical preparation industry in Beijing

Eight, Shandong chemical operation.

Nine. Operation situation of chemical preparation industry in Henan Province

X. Operation of Sichuan Chemical Industry

Section 6 Operation of Leading Enterprises of Chemical Preparations

I. Operation of Top Ten Chemical Reagent Enterprises in 2003-2005

Two, 2003-2005 100 chemical enterprises.

Section 7 Foreign Trade of Chemical Preparations in China

I. General situation

Two. Imports from 2002 to 2005

Three. Export situation from 2002 to 2005

Fourth, the export of chemical reagents.

Verb (abbreviation of verb) foreign trade policy of chemical preparations

Part IV Traditional Chinese Medicine Industry

Chapter 10 Analysis of Traditional Chinese Medicine Pieces Industry

Section 1 General Operation of Chinese Herbal Pieces

I. Profits and losses of Chinese herbal pieces industry from 2002 to 2005

Two, 2002-2005 Chinese herbal medicine industry production and marketing situation

III. Industrial Benefits of Chinese Herbal Medicine in 2002-2005

Four. Development Index of Chinese Herbal Pieces Industry from 2002 to 2005

Section 2 economies of scale of Chinese herbal pieces

I. Profits and losses of large, medium and small enterprises of Chinese herbal pieces from 2002 to 2005

Two, 2002-2005, the production and sale of Chinese herbal pieces of large, medium and small enterprises.

Three, 2002-2005, Chinese herbal pieces of large, medium and small enterprises benefit.

Four, 2002-2005 Chinese herbal medicine large, medium and small enterprises development indicators

Section 3 Property Right Economy of Chinese Herbal Pieces

I. Economic gains and losses of property rights of Chinese herbal pieces from 2002 to 2005

Two, 2002-2005, the economic production and marketing of Chinese herbal pieces.

Third, the economic benefits of property rights of Chinese herbal pieces in 2002-2005

Four, 2002-2005 Chinese herbal pieces of property rights economic development index

Section 4 Output of Traditional Chinese Medicine Pieces

I. Output growth in 2002-2005

II. Monthly Changes of Chemical Raw Materials and Drugs in 2004-2005

Three, the main areas of Chinese herbal medicine production

Section 5 Operation of Traditional Chinese Medicine Pieces in Key Areas

I. General situation

Second, Guangdong area

Third, Guangxi.

Fourth, Sichuan area.

Verb (abbreviation of verb) Jiangsu area

Sixth, Jilin area.

Seven, Zhejiang area

Section 6 Operation of Leading Enterprises of Traditional Chinese Medicine Pieces

1.2003-2005 analysis of the operation of the top ten Chinese herbal pieces enterprises.

2. Analysis of Top Chinese Herbal Pieces 100 Enterprises in 2003-2005

Chapter III XI Analysis of Chinese Patent Medicine Industry

Section 1 General Operation of Chinese Patent Medicines

I. Profits and losses of Chinese patent medicine industry from 2002 to 2005

II. Production and marketing of Chinese patent medicine industry in 2002-2005

Three. Benefit analysis of Chinese patent medicine industry from 2002 to 2005

IV. Development Index of Chinese Patent Medicine Industry in 2002-2005

Section 2 economies of scale of Chinese patent medicines

I. Profits and losses of Chinese patent medicine enterprises from 2002 to 2005

Two, 2002-2005, Chinese patent medicine production and sales enterprises.

III. Benefit of Chinese patent medicine enterprises from 2002 to 2005.

Four, 2002-2005, large, medium and small enterprises of Chinese patent medicine development index

Section 3 Property Right Economy of Chinese Patent Medicines

I. Economic Profit and Loss of Chinese Patent Medicines in 2002-2005

Two, 2002-2005, the economic production and marketing of Chinese patent medicine.

Third, the economic benefits of Chinese patent medicines from 2002 to 2005.

Four, 2002-2005 proprietary Chinese medicine property rights economic development index

The fourth quarter of Chinese patent medicine output analysis

I. Output growth in 2002-2005

II. Monthly Changes of Chemical Raw Materials and Drugs in 2004-2005

Three, the main areas of Chinese patent medicine production

Section 5 Management of Chinese Patent Medicines in Key Areas

I. General situation

Second, Guangdong area

Third, Jilin area.

Fourth, Jiangxi area.

Verb (abbreviation of verb) Guizhou area

Sixth, Shandong area.

Seven, Sichuan area

Eight, Zhejiang area

Nine, Tianjin area

X. Beijing area

Section 6 Operation of Leading Chinese Patent Medicine Enterprises

I. Analysis on the Operation of Top Ten Chinese Patent Medicine Enterprises from 2003 to 2005

Two, 2003-2005 100 Chinese patent medicine enterprises.

Chapter XII Analysis of Foreign Trade and Advantages and Disadvantages of Traditional Chinese Medicine

Section 1 Import and Export of Traditional Chinese Medicine and Traditional Chinese Medicine

First, Chinese medicine and Chinese herbal medicine export analysis

Two. General situation of import and export of traditional Chinese medicine and Chinese herbal medicine from 2003 to 2005

Section II Analysis of Advantages, Disadvantages and Development Trend of Chinese Medicine Industry

First, the policy analysis of Chinese medicine industry

Second, the technical analysis of Chinese medicine industry

Third, the analysis of the development prospect of Chinese medicine industry

Fourthly, analyze the problems existing in Chinese medicine industry.

Five, the development trend analysis of traditional Chinese medicine industry

Part v biopharmaceutical industry

Chapter XIII World Biopharmaceutical Industry

Section 1 Global biopharmaceutical market size

Section 2 Listed Companies of Global Biotechnology Companies

Section III Development Trend of Global Biopharmaceutical Industry

I. Global projections

Second, the international market sells the best biopharmaceuticals now and in the future.

Three, the recent (since 2002) will be put into production and is developing the best-selling drugs.

Section 4 American biopharmaceutical industry

First, American biotechnology industry rose again in 2003.

Secondly, biotechnology company highly sought after by capital have become upstart.

Section 5 Biomedical Industry in Japan

I. Status of biopharmaceutical industry in Japan

Second, the long-term scale of Japanese biotechnology industry

Third, the achievements of Japanese protein structure.

Section VI Status quo of biopharmaceutical industry in Germany

Section 7 Market Situation of Major Biopharmaceutical Products in the World

First, the overall situation analysis

Second, the world genetic engineering drug industry analysis

Analysis and forecast of global therapeutic protein market in 2002-20 10

Chapter 14 Analysis of biopharmaceutical industry in China

Section 1 General operation of biopharmaceuticals

I. Profits and losses of biopharmaceutical industry in 2002-2005

Production and marketing of biopharmaceutical industry in 2002-2005

Three. Benefits of biopharmaceutical industry in 2002-2005

IV. Development Index of Biopharmaceutical Industry in 2002-2005

Section 2 economies of scale of biopharmaceuticals

I. Profits and losses of large, medium and small biopharmaceutical enterprises from 2002 to 2005

Production and marketing of large, medium and small biopharmaceutical enterprises in 2002-2005.

Three. Benefit of biopharmaceutical enterprises in 2002-2005

Iv. biopharmaceutical development index of large and medium-sized enterprises in 2002-2005

Section 3 biopharmaceutical property rights economy

I. Economic gains and losses of biopharmaceutical property rights in 2002-2005

II. Economic Production and Marketing of Biomedical Industry in 2002-2005

Third, the economic benefits of biopharmaceutical property rights in 2002-2005

IV. Economic development index of biopharmaceutical industry in 2002-2005

Section IV Development of Biomedical Industry in Different Regions

First, regional economic comparison

Second, Hubei biopharmaceutical industry operation analysis

Three, Zhejiang biopharmaceutical industry operation analysis

Four, Shandong biopharmaceutical industry operation analysis

Verb (abbreviation of verb) Analysis on the operation of Shanghai biopharmaceutical industry

Analysis of Guangdong biopharmaceutical industry operation with intransitive verb

VII. Analysis on the operation of biopharmaceutical industry in Beijing.

Eight, Tianjin biopharmaceutical industry operation analysis

Nine, Jiangsu biopharmaceutical industry operation analysis

Chapter 15 China biopharmaceutical market segments

Section 1 Overall Sales Analysis of Main Products

I. Sales of major biopharmaceuticals

Second, the research and development of genetically engineered drugs.

Section II Production and Sales of Interferon in China

First of all, we produce the main types of interferon.

Second, the market space is large.

Third, the competition is becoming more and more fierce.

Fourth, growth takes time.

Five, the current production of interferon listed companies

Section III Vaccine Market

First of all, the vaccine market in China contains huge business opportunities.

Second, the current situation of vaccine production enterprises in China

Third, the market situation of influenza vaccine

Fourth, the hepatitis B vaccine market.

Section 4 Other market segments

I. Human serum albumin

Second, erythropoietin.

Three. interleukin

Fourthly, colony stimulating factor.

Verb (abbreviation for verb) human growth hormone

Sixth, insulin.

Chapter 16 Operation of Leading Biopharmaceutical Enterprises in China

Section 1 Ranking of Biopharmaceutical Leading Enterprises

1. Sales revenue and profit of biopharmaceutical sales revenue top 10 enterprises in 2004

Two, the National Bureau of Statistics in 2004 biopharmaceutical enterprises sales revenue of the top 200 enterprises.

III. The National Bureau of Statistics makes statistics on the top 200 biopharmaceutical enterprises according to their profits.

Four, the State Economic and Trade Commission to monitor the sales revenue and profit of biopharmaceutical enterprises 100 enterprises.

Section II Business Analysis of Biopharmaceutical Listed Enterprises in China

Chapter 17 Analysis of Import and Export of Biological Drugs

Section I Import of Major Biopharmaceutical Products in 2004

Section II Export of Major Biopharmaceutical Products in 2004

I. Total export volume 390

Two. Export countries, quantity and amount of main products

The sixth part is the analysis of medical terminal market.

Chapter 18 Consumer Analysis

Section 1 Basic information of consumers

I. Composition of urban and rural population in various regions of China

Second, the living standards of the people throughout the country.

Section 2 Analysis of Drug Consumption Structure

I. Urban and rural consumption structure

Second, the rural drug market in China

Three, domestic drugs and imported drugs, joint venture drug market share

The third quarter consumer psychology analysis

First, the psychological analysis of consumers buying drugs

Second, consumers' choice of Chinese and western medicines.

Third, the patient's medical habits.

Section 4 Consumers' Standing Medicines

First, there are three major drugs at home.

Second, the purchase channels of standing drugs

Section 5 Changes of Disease Incidence Patterns

I. Changes of global incidence patterns in the 20th century (265-438+0)

Second, the incidence pattern of diseases in China population.

Chapter XIX Current Situation of Sales Channels in Pharmaceutical Market

Section 1 Current Situation of Drug Sales Channels

First, the sales channels and sales models of medicine

Second, the status quo of the pharmaceutical retail industry

Third, the main operators realize the large-scale development of pharmaceutical retail industry.

Fourth, the analysis of pharmaceutical wholesale market

Five, China drug retail meets the challenge.

Section II Current Situation of Medical Services in China

I. Analysis of industrial organization

Second, the status of medical services

Section III Current Situation of Pharmaceutical Chain Operation

I. General situation of pharmaceutical chain operation

Second, the business model of American chain retail pharmacies

Third, the socialization of pharmaceutical chain distribution.

Four, pharmaceutical chain management analysis

Chapter 20 Market segments of main drugs used in hospitals

Section 1 Application of Macrolide Antibiotics in Hospital

I. Overview of main antibiotic types

Second, the market scale of macrolides has grown steadily.

Thirdly, azithromycin, roxithromycin and clarithromycin were outstanding.

Fourth, the development prospect of macrolide antibiotics

Section 2 Analysis on the Sales of Penicillins in Hospitals in China

Analysis of Amoxicillin/Potassium Clavulanate Used in Hospital in the Third Quarter

First, medical drugs-the growth rate has slowed down significantly.

Second, domestic manufacturers-redistribution of market share

Third, market share-the rise of traditional Chinese medicine and the decline of foreign medicine

The fourth quarter vancomycin hospital drug use analysis

First, the total amount of vancomycin used.

Second, the use of vancomycin city

Three. Sales situation of vancomycin production enterprises

Fourth, the proportion of domestic and imported products.

Section V Hospital Market Analysis of β -lactamase Inhibitors

Section VI Analysis on the Use of Cephalosporins

Section 7 Analysis of Key Varieties of Quinolones

I. Levofloxacin

Second, ciprofloxacin.

Three. Ofloxacin

Four. Fleroxacin

Verb (abbreviation of verb) norfloxacin

The intransitive verb gatifloxacin

Section 7 Analysis of the Use of Systemic Hormones in Hospitals

Section 8 Use of Secret Treatment Drugs in Hospitals

Section 9 Digestive System Drug Hospital Market

Section 10 Respiratory Medicine Market

1. Market Trend of Respiratory Drugs in China Hospital in 2002

Second, the hospital market analysis of respiratory drugs

Third, the market situation of the main varieties

Four. Analysis on Retail Market of Respiratory Medicine

V. Market analysis of asthma drugs

Market Analysis of External Skin Drug XI in China in 2003

I. General situation in 2003

Second, the market characteristics

Third, the specific brand analysis

Four. Analysis of market situation in 2002

Section 12 Analysis of Eye Drops Market

Section 13 Market of Plant Alkaloids Antitumor Drugs in Major Cities of China